Rheumatology International

, Volume 31, Issue 12, pp 1555–1559 | Cite as

Subgrouping patients with fibromyalgia according to the results of the fibromyalgia impact questionnaire: a replication study

  • Elena P. Calandre
  • Jocelyne Garcia-Carrillo
  • Juan M. Garcia-Leiva
  • Fernando Rico-Villademoros
  • Rocío Molina-Barea
  • Carmen M. Rodriguez-Lopez
Original Article

Abstract

Fibromyalgia is a complex and heterogeneous disease, and several attempts have been made in order to identify different subgroups of patients sharing a common symptomatology. The purpose of the present study has been to replicate a subgroup classification proposed by de Souza et al. based in the Fibromyalgia Impact Questionnaire (FIQ) in a large sample of patients with a cultural and clinical setting different from the original one. Four hundred twenty-one patients were classified, according to the results of the visual analog FIQ subscales in type I o type II subgroups. Demographic and clinical data, as well as results of scales assessing disease’s severity, quality of life, sleep quality, anxiety and depression, were compared between the two groups. The profiles of type I and type II patients from our sample strikingly paralleled those of the original study, demonstrating the reproducibility of the classification. In our sample, 18.8% of the patients appertained to type I subgroup and 81.2% to type II subgroup. Patients from this later subgroup had higher comorbidity and received more drugs than those of the former. They were also more physically ill, with higher FIQ total scores and worse sleep quality, and more psychologically distressed, with higher levels of anxiety and depression and lower scores in the mental component summary of the Short-Form Health Questionnaire (SF-12). Our study shows that the proposed fibromyalgia classification is reliable and easy to perform and could be applied in further studies.

Keywords

Fibromyalgia Subgroups Fibromyalgia impact questionnaire Cross-sectional Replication study 

References

  1. 1.
    Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL et al (1990) The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum 33:160–172PubMedCrossRefGoogle Scholar
  2. 2.
    Sumpton JE, Moulin DE (2008) Fibromyalgia: presentation and management with a focus on pharmacological treatment. Pain Res Manag 13:477–483PubMedGoogle Scholar
  3. 3.
    Mease P (2005) Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment. J Rheumatol 32(Suppl 75):6–21Google Scholar
  4. 4.
    de Tommaso M, Sardaro M, Serpino C, Constantini F, Vecchio E, Prudenzano MP et al (2009) Fibromyalgia comorbidity in primary headaches. Cephalalgia 29:453–464PubMedCrossRefGoogle Scholar
  5. 5.
    Cole JA, Rothman KJ, Cabral HJ, Zhang Y, Farraye FA (2006) Migraine, fibromyalgia, and depression among people with IBS: a prevalence study. BMC Gastroenterol 6:26PubMedCrossRefGoogle Scholar
  6. 6.
    Kurland JE, Coyle WJ, Winkler A, Zable E (2006) Prevalence of irritable bowel syndrome and depression in fibromyalgia. Dig Dis Sci 51:454–460PubMedCrossRefGoogle Scholar
  7. 7.
    Balasubramanian R, de Leeuw R, Zhu H, Nickerson RB, Okeson JP, Carlson CR (2007) Prevalence of temporomandibular disorders in fibromyalgia and failed back syndrome patients: a blinded prospective comparison study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104:204–216CrossRefGoogle Scholar
  8. 8.
    Aaron LA, Burke MM, Buchwald D (2000) Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder. Arch Intern Med 160:221–227PubMedCrossRefGoogle Scholar
  9. 9.
    Bradley LA (2005) Psychiatric comorbidity in fibromyalgia. Curr Pain Headache Rep 9:79–86PubMedCrossRefGoogle Scholar
  10. 10.
    Arnold LM (2008) Management of fibromyalgia and comorbid psychiatric disorders. J Clin Psychiatry 69(Suppl 2):14–19PubMedGoogle Scholar
  11. 11.
    Turk DC, Okifuji A, Sinclair JD, Starz TW (1998) Differential responses by psychosocial subgroups of fibromyalgia syndrome patients to an interdisciplinary treatment. Arthritis Care Res 11:397–404PubMedCrossRefGoogle Scholar
  12. 12.
    Verra ML, Angst F, Brioschi R, Lehmann S, Keefe FJ, Staal JB et al (2009) Does classification of persons with fibromyalgia into Multidimensional Pain Inventory subgroups detect differences in outcome after a standard chronic pain management program? Pain Res Manag 2009(14):445–453Google Scholar
  13. 13.
    Giesecke T, Williams DA, Harris RE, Cupps TR, Tian X, Gracely RH et al (2003) Subgrouping of fibromyalgia patients on the basis of pressure-pain thresholds and psychological factors. Arthritis Rheum 48:2916–2922PubMedCrossRefGoogle Scholar
  14. 14.
    Häuser W, Schmutzer G, Brähler E, Graesmer H (2009) A cluster within the continuum of biopsychosocial distress can be labeled “fibromyalgia syndrome”—evidence from a representative german population survey. J Rheumatol 36:2806–2812PubMedCrossRefGoogle Scholar
  15. 15.
    Wilson HD, Robinson JP, Turk DC (2009) Toward the identification of symptom patterns in people with fibromyalgia. Arthritis Care Res 61:527–534CrossRefGoogle Scholar
  16. 16.
    de Souza JB, Goffaux P, Julien N, Potvin S, Charest J, Marchand S (2009) Fibromyalgia subgroups: profiling distinct subgroups using the Fibromyalgia Impact Questionnaire. A preliminary study. Rheumatol Int 29:509–515PubMedCrossRefGoogle Scholar
  17. 17.
    Hidalgo J, Rico-Villademoros F, Calandre EP (2007) An open-label study of quetiapine in the treatment of fibromyalgia. Prog Neuropsychopharmacol Biol Psychiatry 31:71–77PubMedCrossRefGoogle Scholar
  18. 18.
    Calandre EP, Hidalgo J, Rico-Villademoros F (2007) Use of ziprasidone in patients with fibromyalgia: a case series. Rheumatol Int 27:473–476PubMedCrossRefGoogle Scholar
  19. 19.
    Rico-Villademoros F, Hidalgo J, Morillas-Arques P, Vilchez JS, Delgado-Rodriguez A, Calandre EP (2009) An open-label study of levopromazine (methotrimeprazine) as add-on therapy in fibromyalgia management. Clin Exp Rheumatol 27(Suppl 56):S16–S20PubMedGoogle Scholar
  20. 20.
    Calandre EP, Rodriguez-Claro ML, Rico-Villademoros F, Vilchez JS, Hidalgo J, Delgado-Rodriguez A (2009) Effects of pool-based exercise in fibromyalgia symptomatology and sleep quality: a prospective, randomised comparison between stretching and Ai Chi. Clin Exp Rheumatol 26(Suppl 56):S21–S28Google Scholar
  21. 21.
    Calandre EP, Molina-Barea R, Morillas-Arques P, Rodriguez-Lopez CM, Garcia-Leiva JM, Rico-Villademoros F (2008) Trazodone in the treatment of fibromyalgia: a 12-weeks open label study. Int J Neuropsychopharmacol 11(suppl 1):302Google Scholar
  22. 22.
    Garcia-Leiva JM, Molina-Barea R, Rodriguez-Lopez CM, Morillas-Arques P, Garcia-Carrillo J, Calandre EP (2009) Ropinirole in the treatment of refractory fibromyalgia: a case series. Eur J Pain 13(suppl 1):S149CrossRefGoogle Scholar
  23. 23.
    Calandre EP, Rodriguez-Claro ML (2000) A randomized, controlled-trial comparing the efficacy and tolerability of Ai Chi versus stretching in fibromyalgia management: a six-months study. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (USA). 2000-[cited 2010 January 30]. Available from: http://clinicaltrials.gov/show/NCT00004451. NLM Identifier: NCT00600574
  24. 24.
    Bennett R (2005) The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses. Clin Exp Rheumatol 23(5 Suppl 39):S154–S162PubMedGoogle Scholar
  25. 25.
    Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ (1989) The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res 28:193–213PubMedCrossRefGoogle Scholar
  26. 26.
    Ware JE Jr, Kosinski M, Keller S (1996) A 12-item short-form health survey. Med Care 34:220–233PubMedCrossRefGoogle Scholar
  27. 27.
    Beck AT, Ward CH, Mendelson M, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571PubMedGoogle Scholar
  28. 28.
    Spielberger CD (1984) State-trait anxiety inventory: a comprehensive bibliography. Consultant Psychologists Press, Palo AltoGoogle Scholar
  29. 29.
    Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370PubMedCrossRefGoogle Scholar
  30. 30.
    Wilson HD, Starz TW, Robinson JP, Turk DC (2009) Heterogeinity within the fibromyalgia population: theoretical implications of variable tender points severity ratings. J Rheumatol 36:2795–2801PubMedCrossRefGoogle Scholar
  31. 31.
    Bigatti SM, Hernandez AM, Cronan TA, Rand KL (2008) Sleep disturbances in fibromyalgia syndrome: relationship to pain and depression. Arthritis Care Res 59:961–967CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Elena P. Calandre
    • 1
  • Jocelyne Garcia-Carrillo
    • 1
  • Juan M. Garcia-Leiva
    • 1
  • Fernando Rico-Villademoros
    • 1
  • Rocío Molina-Barea
    • 1
  • Carmen M. Rodriguez-Lopez
    • 1
  1. 1.Instituto de Neurociencias, Centro de Investigaciones Biomédicas (CIBM), Universidad de GranadaGranadaSpain

Personalised recommendations